Drug Type Small molecule drug |
Synonyms 3-propylxanthine |
Action antagonists |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), ADORA2 antagonists(Adenosine A2 receptor antagonists), Adenosine receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC8H10N4O2 |
InChIKeySIQPXVQCUCHWDI-UHFFFAOYSA-N |
CAS Registry41078-02-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Enprofylline | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute asthma | Preclinical | Thailand | 01 Nov 1990 | |
Lung Diseases, Obstructive | Preclinical | Canada | 01 Feb 1990 | |
Bronchial Diseases | Preclinical | United Kingdom | 01 Jan 1989 |